What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Radiation therapy
Howard M. Sandler focuses on Radiation therapy, Prostate cancer, Prostate, Surgery and Internal medicine.
His Radiation therapy research includes elements of Salvage therapy, Proportional hazards model, Nuclear medicine and Urology.
His biological study spans a wide range of topics, including Gynecology and Brachytherapy.
He combines subjects such as Pelvis, Dose fractionation, Rectum, Toxicity and Adenocarcinoma with his study of Prostate.
Howard M. Sandler interconnects Relative risk and Radiology in the investigation of issues within Surgery.
His research on Internal medicine frequently connects to adjacent areas such as Oncology.
His most cited work include:
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference (1831 citations)
- Quality of life and satisfaction with outcome among prostate-cancer survivors. (1747 citations)
- Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. (1098 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Prostate cancer, Radiation therapy, Internal medicine, Oncology and Prostate.
While the research belongs to areas of Prostate cancer, Howard M. Sandler spends his time largely on the problem of Urology, intersecting his research to questions surrounding Toxicity.
His work carried out in the field of Radiation therapy brings together such families of science as Hormonal therapy, Proportional hazards model and Nuclear medicine.
Much of his study explores Internal medicine relationship to Gynecology.
His research investigates the connection between Oncology and topics such as Chemotherapy that intersect with problems in Bladder cancer.
His work deals with themes such as Rectum, Univariate analysis and Adenocarcinoma, which intersect with Prostate.
He most often published in these fields:
- Prostate cancer (62.14%)
- Radiation therapy (52.77%)
- Internal medicine (52.20%)
What were the highlights of his more recent work (between 2015-2021)?
- Prostate cancer (62.14%)
- Internal medicine (52.20%)
- Oncology (48.57%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Radiation therapy and Randomized controlled trial.
His study in Prostate cancer is interdisciplinary in nature, drawing from both Stage, Prostate and Clinical trial.
The Oncology study combines topics in areas such as Evidence based guideline, Phases of clinical research, Meta-analysis, Hazard ratio and Prostate-specific antigen.
Within one scientific family, Howard M. Sandler focuses on topics pertaining to Prospective cohort study under Radiation therapy, and may sometimes address concerns connected to Brachytherapy.
The study incorporates disciplines such as Disease and Salvage radiotherapy in addition to Randomized controlled trial.
As part of one scientific family, Howard M. Sandler deals mainly with the area of Prostatectomy, narrowing it down to issues related to the Surgery, and often Radiology.
Between 2015 and 2021, his most popular works were:
- Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer (291 citations)
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options (272 citations)
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer (271 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Radiation therapy
Howard M. Sandler spends much of his time researching Prostate cancer, Internal medicine, Oncology, Radiation therapy and Randomized controlled trial.
His Prostate cancer research is multidisciplinary, incorporating elements of Stage, Guideline and Prostate.
His Prostate study integrates concerns from other disciplines, such as External beam radiotherapy and Urology.
His Internal medicine research incorporates themes from Heredity and Gynecology.
His Oncology research is multidisciplinary, relying on both Phases of clinical research, Hazard ratio, Biochemical recurrence, Prospective cohort study and Genetic testing.
Radiation therapy is a subfield of Surgery that Howard M. Sandler tackles.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
